Showing results (871-880 of 956) with videos related to
Sort By:
Pageof 96
The Lancet. Gastroenterology & Hepatology|January 22, 2022
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trialThomas U Marron, Maria Isabel Fiel, Pauline Hamon, et al.Biorxiv : the Preprint Server for Biology|January 7, 2025
Dendritic cells type 1 control the formation, maintenance, and function of tertiary lymphoid structures in cancerRaphaël Mattiuz, Jesse Boumelha, Pauline Hamon, et al.Pathogens (Basel, Switzerland)|June 24, 2022
Cryptococcal Meningitis in Kidney Transplant Recipients: A Two-Decade Cohort Study in FranceLaurène Tardieu, Gillian Divard, Olivier Lortholary, et al.Nature Medicine|June 15, 2023
Intratumoral dendritic cell-CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinomaAssaf Magen, Pauline Hamon, Nathalie Fiaschi, et al.Nature Medicine|January 27, 2026
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockadeEdgar Gonzalez-Kozlova, Robert Sweeney, Igor Figueiredo, et al.European Radiology|May 4, 2020
National dose reference levels in computed tomography-guided interventional procedures-a proposalJoël Greffier, Gilbert Ferretti, Julia Rousseau, et al.European Radiology|June 6, 2020
Correction to: National dose reference levels in computed tomography-guided interventional procedures-a proposalJoël Greffier, Gilbert Ferretti, Julia Rousseau, et al.The Lancet. Respiratory Medicine|November 29, 2021
Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID studyJean-Pierre Gangneux, Eric Dannaoui, Arnaud Fekkar, et al.Science (New York, N.Y.)|July 16, 2026
Dendritic cells control tertiary lymphoid structure development and maintenance in cancerRaphaël Mattiuz, Jesse Boumelha, Emmanouil Aerakis, et al.Pageof 96